Curated GI articles February 3rd, 2023: FDA approves neurostimulator for incontinence | Study: Virtual GI care saves $10k per patient

Curated GI articles February 3rd, 2023:
FDA approves neurostimulator for incontinence | Study: Virtual GI care saves $10k per patient

Podcast: Robbie Allen, CEO of One GI (Becker’s GI & Endoscopy)
Robbie Allen (CEO of One GI) discusses the future of physician employment in the midst of dwindling numbers of independent physician groups, different generational perspectives on work, and more.

FDA approves 4th-generation neurostimulator for fecal incontinence, overactive bladder (Healio)
The FDA has approved Axonics Inc’s fourth-generation R20 rechargeable sacral neuromodulation system for bladder and bowel dysfunction.

Clinical Trial Results Demonstrate Oshi Health’s Multidisciplinary GI Care Improves Patient Outcomes with Savings Greater than $10,000 Per Patient Within 6 Months (PR Web)
The findings are important as digestive disorders are very common and have a high economic burden, affecting more than 70 million people in the U.S.

The future of GI (MDedge)
Judy A. Trieu, MD, MPH, the Editor-in-Chief and Advanced Endoscopy Fellow of the Division of Gastroenterology & Hepatology at the University of North Carolina at Chapel Hill, gives an overview of the articles regarding the future of GI.

Can AI Conquer the Late-Shift Dip in Colonoscopy Quality? (Medscape)
New research confirms that colonoscopies conducted later in an endoscopist’s shift are associated with a decline in adenoma detection and demonstrates that AI can help eliminate the problem.

Private Equity and Digital Health in 2023: Policy Updates and Trends to Watch (JD Supra)
The following serves as a broad overview of recent policy updates and areas of opportunity in 2023.

Salve Lucrum: The Existential Threat of Greed in US Health Care (JAMA Network)
The grip of financial self-interest in US health care is becoming a stranglehold, with dangerous and pervasive consequences.

Gut-Directed Hypnotherapy App Improves IBS Symptoms (GI & Endoscopy News)
A gut-directed hypnotherapy program conducted via a downloadable app was shown to improve GI symptoms —and to a degree that is similar to that seen in face-to-face therapy.

Ayble Health Recognized as the First and Only Gastroenterology Company to Achieve Certification from the Validation Institute for IBS and IBD Patient Outcomes (Ayble Health)
Ayble Health is tenacious in its pursuit to transform the standard of care for GI patients. Sam Jactel (CEO, Ayble Health) was recently interviewed on The Scope Forward Show.

Why are so many physicians quitting medicine? The real reasons revealed (KevinMD)
What will the health care system do with so many physicians leaving medicine? This article reviews two reasons physicians leave their current roles for something else.

Salvo Health & Gemelli Biotech partner to offer cutting-edge diagnostic testing for IBS and SIBO across 29 states (Salvo Health)
The partnership will provide access to advanced breath testing and IBS blood testing not generally available in most doctor’s offices.

Doctors, Get Ready for Your AI Assistants (WIRED)
Hospitals have begun using machine learning to help analyze and collect images, and the medical applications are endless.

10 gastroenterologists in the headlines (Becker’s GI & Endoscopy)
A compilation of gastroenterologists who have made news headlines, by Becker’s Healthcare.

Income Could Plunge for Out-of-Network Doctors (Medscape)
Out-of-network (OON) status has been financially advantageous for doctors, but in recent years, insurers have been making it harder to be OON.

Minimally invasive endoscopic therapies for gastro-oesophageal reflux disease (BMJ)
In recent years, several minimally invasive antireflux endoscopic therapies (ARET) have been developed which may play a role in bridging the unmet therapeutic gap.

New Treatment Recommendations for Early-Onset CRC (Medscape)
An international group of physicians has issued consensus recommendations for the diagnosis and management of patients with early-onset colorectal cancer (eoCRC).

Assessment of the Role of Artificial Intelligence in the Association Between Time of Day and Colonoscopy Quality (JAMA Network)
The findings suggest AI systems may be a potential tool for minimizing time-related degradation of colonoscopy quality.

‘Evidence supports’ de-escalating combination therapy in patients with IBD after 1 year (Healio)
Providers should consider de-escalating combination therapy with immunomodulators to monotherapy after 1 year in patients with inflammatory bowel disease, according to a presenter at the Crohn’s and Colitis Congress.

MORE HOT HEADLINES

Register: 2023 AGA Tech Summit (AGA)

Young, gifted and Black: 3 GIs making an impact (AGA)

Virginia lawmakers push for greater coverage of colon cancer screening costs (Becker’s GI & Endoscopy)

It’s ‘telehealth vs. no care’: Doctors say Congress risks leaving patients vulnerable (News Medical)

‘I Cry but No One Cares’: Physician Burnout & Depression Report 2023 (Medscape)

4 gastroenterology, endoscopy facility openings in 2 weeks (Becker’s GI & Endoscopy)

Video: Medical Uses of ChatGPT (The Medical Futurist)

Patients with IBD, ‘higher social vulnerability’ inadequately screened for mental health (Healio)

Combination biologic therapy for ulcerative colitis (The Lancet GI & Hepatology)

Predicting Barrett’s Esophagus, Esophageal Adenocarcinoma 5 Years Before Diagnosis (GI & Endoscopy News)

Videos: Interviews with GI Leaders  (Scope Forward Show/NextServices)

_

COVID-19: The Way Forward for Gastroenterology Practices
COVID-19 is a double whammy of both clinical and business disruption. This ebook will help you explore possible scenarios and be a guide in your plans for the future.